T.M. Behr
Department of Nuclear Medicine
Georg-August-University
Göttingen
Germany
Name/email consistency: high
- Therapeutic advantages of Auger electron- over beta-emitting radiometals or radioiodine when conjugated to internalizing antibodies. Behr, T.M., Béhé, M., Löhr, M., Sgouros, G., Angerstein, C., Wehrmann, E., Nebendahl, K., Becker, W. Eur. J. Nucl. Med (2000)
- High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model. Behr, T.M., Béhé, M., Stabin, M.G., Wehrmann, E., Apostolidis, C., Molinet, R., Strutz, F., Fayyazi, A., Wieland, E., Gratz, S., Koch, L., Goldenberg, D.M., Becker, W. Cancer Res. (1999)
- Cholecystokinin-B/gastrin receptor binding peptides: preclinical development and evaluation of their diagnostic and therapeutic potential. Behr, T.M., Béhé, M., Angerstein, C., Gratz, S., Mach, R., Hagemann, L., Jenner, N., Stiehler, M., Frank-Raue, K., Raue, F., Becker, W. Clin. Cancer Res. (1999)
- Radioimmunotherapy of small volume disease of colorectal cancer metastatic to the liver: preclinical evaluation in comparison to standard chemotherapy and initial results of a phase I clinical study. Behr, T.M., Salib, A.L., Liersch, T., Béhé, M., Angerstein, C., Blumenthal, R.D., Fayyazi, A., Sharkey, R.M., Ringe, B., Becker, H., Wörmann, B., Hiddemann, W., Goldenberg, D.M., Becker, W. Clin. Cancer Res. (1999)
- Low- versus high-dose radioimmunotherapy with humanized anti-CD22 or chimeric anti-CD20 antibodies in a broad spectrum of B cell-associated malignancies. Behr, T.M., Wörmann, B., Gramatzki, M., Riggert, J., Gratz, S., Béhé, M., Griesinger, F., Sharkey, R.M., Kolb, H.J., Hiddemann, W., Goldenberg, D.M., Becker, W. Clin. Cancer Res. (1999)
